Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy

Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cell...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ran Li, Yimei Wang, Jie Du, Xiangyu Wang, Ailin Duan, Ruifang Gao, Junyu Liu, Bing Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a72
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91d687fcae1f40e2bbb08d73a1ee3a72
record_format dspace
spelling oai:doaj.org-article:91d687fcae1f40e2bbb08d73a1ee3a722021-12-02T10:49:30ZGraphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy10.1038/s41598-021-81218-32045-2322https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a722021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81218-3https://doaj.org/toc/2045-2322Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency.Ran LiYimei WangJie DuXiangyu WangAilin DuanRuifang GaoJunyu LiuBing LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ran Li
Yimei Wang
Jie Du
Xiangyu Wang
Ailin Duan
Ruifang Gao
Junyu Liu
Bing Li
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
description Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency.
format article
author Ran Li
Yimei Wang
Jie Du
Xiangyu Wang
Ailin Duan
Ruifang Gao
Junyu Liu
Bing Li
author_facet Ran Li
Yimei Wang
Jie Du
Xiangyu Wang
Ailin Duan
Ruifang Gao
Junyu Liu
Bing Li
author_sort Ran Li
title Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
title_short Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
title_full Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
title_fullStr Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
title_full_unstemmed Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
title_sort graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a72
work_keys_str_mv AT ranli grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT yimeiwang grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT jiedu grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT xiangyuwang grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT ailinduan grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT ruifanggao grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT junyuliu grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
AT bingli grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy
_version_ 1718396604823633920